COGHLAN JOHN PHILIP 4
4 · Life360, Inc. · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Life360 (LIF) Director John Coghlan Sells $176.6K of Stock
What Happened
John Philip Coghlan, a director of Life360, reported selling a total of 4,000 shares of Life360 common stock on May 1, 2026. The filing shows two open-market sales: 3,736 shares at a weighted average price of $44.12 for $164,832, and 264 shares at a weighted average price of $44.67 for $11,793, for aggregate proceeds of $176,625. These were sales (dispositions), which are often routine and do not necessarily signal a change in the director’s view of the company.
Key Details
- Transaction date: May 1, 2026; Form 4 filed May 5, 2026 (filed on the second business day — timely).
- Sales:
- 3,736 shares — weighted avg price $44.12; total $164,832 (shares sold across prices ranging $43.59–$44.56).
- 264 shares — weighted avg price $44.67; total $11,793 (shares sold across prices ranging $44.59–$44.70).
- Total shares sold: 4,000; total proceeds: $176,625.
- Footnotes: the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Coghlan on Dec 8, 2025 (a pre-arranged plan established when he was not aware of material nonpublic information). The filing notes weighted-average price ranges (the reporter will provide per-share breakouts on request).
- F4 note: the filing references 836 restricted stock units (RSUs), each representing a contingent right to one share.
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
Context
Rule 10b5-1 plans allow insiders to sell shares according to a pre-set formula and schedule; sales under such plans are commonly viewed as planned/automatic rather than opportunistic. Sales (S) are routine reporting of disposals — purchases generally attract more attention as a stronger positive signal. The filing offers to provide detailed per-price sale breakdowns upon request (per footnotes).
Insider Transaction Report
- Sale
Common stock
[F1][F2]2026-05-01$44.12/sh−3,736$164,832→ 32,695 total(indirect: By Trust) - Sale
Common stock
[F1][F3]2026-05-01$44.67/sh−264$11,793→ 32,431 total(indirect: By Trust)
- 836
Common stock
[F4] - 55,494(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
- [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.59 to $44.56, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.59 to $44.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
- [F4]Represents 836 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.